
Mometasone: A mid-strength prescription steroid applied once a day for eczema, psoriasis and other itchy rashes. Strong enough to settle a flare, measured enough for short courses on most of the body. Vtama: A once-daily steroid-free cream for plaque psoriasis. It can be used anywhere on the body, including the face and skin folds, and some people stay clear for months after stopping.


Choose to settle an eczema or psoriasis flare on the body with a once-daily, mid-strength steroid.
Choose for psoriasis or eczema anywhere on the body when you want a once-daily non-steroid with no time limit.
Can you take them together?
They can share a plan: mometasone for flares and Vtama for steroid-free maintenance.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.










Activates steroid receptors: Binds receptors inside skin and immune cells. Turns down inflammatory signals: Changes gene activity to reduce inflammatory messengers. Eases redness and itch: Swelling and irritation settle as inflammation falls.
Simplified glucocorticoid receptor-mediated effects in steroid-responsive skin inflammation. Full effects also involve other pathways. No claim of antimicrobial action or cure; formulation and potency affect clinical use.

Activates AhR: Binds a receptor that helps regulate skin-cell behavior. May rebalance inflammation: Changes in immune signaling may help calm skin. May support the skin barrier: Changes in barrier proteins may help skin function.
Tapinarof is an AhR agonist; the specific therapeutic mechanisms are unknown. Anti-inflammatory and barrier effects are proposed from experimental evidence and are explicitly qualified.
When to Apply: Once a day, a thin film on the rash only, not the skin around it. A fingertip length covers roughly two flat palms. Moisturizer can go on the same skin at other times.
How to Start: Once daily from day one until the skin is smooth and not itchy, usually a few days to two weeks. Under-using it is the commoner mistake. Then stop, or step down to twice a week if your doctor set that up.
If It Irritates: A short sting on cracked or raw skin is common and settles as the skin heals. Moisturizing twenty minutes before or after helps. Burning that worsens over days can mean infection, a reaction to the base, or the wrong diagnosis.
If It’s Not Working: Two weeks of daily use with no change means something else is going on — too little applied, a fungal or infected rash that steroids make worse, or a rash needing a stronger cream or a different drug. Do not keep going past that without a review.
When to Apply: Once a day, at whatever time you will remember. A thin layer over the plaques, rubbed in. It can go on the face, eyelids, armpits, groin and under the breasts, which sets it apart from a steroid. Wash your hands afterwards unless your hands are being treated.
How to Start: Once daily from day one, on every plaque you want treated. No ramp-up, and no cap on how much of the body can be covered, so it does not have to be rationed the way a strong steroid does.
If It Irritates: Small red bumps around hair follicles are the most common problem and usually appear in the first few weeks. Most are not infection and often settle without stopping. Stinging or a rash where you applied it is the other pattern, and that one is worth showing your doctor, because a true contact allergy means stopping.
If It’s Not Working: There is one strength, so there is nothing to increase. Give it a full twelve weeks. If plaques are still thick then, the conversation is about adding something else, phototherapy, or moving to a tablet or injection.
No blood tests for ordinary use. Monitoring is looking at the skin: is the treated area thinner or shinier than the skin beside it, are small veins showing, are there stretch marks in the folds or pus bumps around hair follicles.
The exception is large-area, long-term or covered use, and use in small children, where enough can be absorbed to affect the body’s own steroid production. Uncommon, and why a doctor sets an area and a time limit.
The checkpoint is a review at two to four weeks. Using it most weeks over months means the question is no longer the cream but what long-term treatment should be doing this job.
No blood tests are required. There is nothing to check on a lab report, which is one of the practical arguments for a topical over a tablet.
Monitoring is a look at the skin and a conversation, usually at about twelve weeks. Two things get asked about: folliculitis, and whether it is a few bumps or enough to be a problem; and whether the treated skin has become itchy and inflamed in a new way, which points to contact dermatitis rather than psoriasis.
Long term there is no organ risk to track and no skin thinning to watch for, so there is no maximum duration. What is genuinely not known yet is what many years of continuous use looks like, because the drug is recent. A common pattern is to treat until clear, stop, and restart when plaques come back.
Approximate windows, not promises.
First few minutesApplying it: A thin layer once a day, on the affected skin only.
First few minutesApplying it: A thin layer once a day on the plaques.
Days 1 to 3Itch first: Itch eases before the rash looks different. Normal, and not a reason to add more.
Days 3 to 14Working: Redness fades, scale flattens, weeping stops. Most short courses finish here, and moisturizer keeps going after the steroid stops.
Weeks 2 to 4Judge it here: If it is clear, stop or move to twice-weekly maintenance.
Weeks 2 to 6Psoriasis plaques: Scale lifts and plaques flatten. Something else usually runs alongside, since steroids rarely hold psoriasis on their own.
Weeks to monthsThickened, leathery patches: Skin rubbed and scratched for a long time takes longest, because the thickening itself has to reverse.
Beyond a few weeks of continuous useThe risks: Thinning skin, visible small veins, stretch marks in folds, small pus bumps around hair follicles. Uncommon on short courses, and why long courses are planned rather than drifted into.
Weeks 1 to 4Starting: Scale and roughness ease before the redness does, often by week four. Folliculitis shows up now if it is going to, usually small tender bumps in hair-bearing areas.
Weeks 4 to 8Working: Plaques flatten and shrink, and color fades from red toward pink or brown.
Weeks 8 to 12Judge it here: Trials measured their main result at twelve weeks, and many people were still improving then. A meaningful minority reached clear or almost clear skin — a realistic target, not a promise.
After stoppingRemission: Unlike a steroid, it does not usually rebound. People who cleared completely often stayed clear for months before restarting.
Sorted by what to do about them.
Generic mometasone is inexpensive and widely stocked, and the cream and ointment are on most low-cost generic lists. The Elocon brand costs considerably more for the same molecule.
The lotion and scalp solution usually cost more, and are sometimes the versions a plan will not cover. If cost is the issue, ask whether a different base at the same 0.1% would do the job.
Brand only, with no generic. It is one of the more expensive topicals for psoriasis and costs far more than a generic steroid or generic calcipotriene.
Coverage varies and prior authorization is common; plans frequently want to see a topical steroid, and often a vitamin D analog, tried first. Manufacturer copay cards exist and the terms change, so check the current one.
Because a tube covers only so much, cost climbs quickly with widespread psoriasis, which is one of the main reasons people end up on a tablet or injection instead.
Two to four weeks on a defined area. Longer should be your doctor's decision, usually as twice-weekly maintenance.
Only if your doctor said so, and briefly. Facial skin absorbs far more and shows thinning first. Milder or non-steroid creams are usually chosen there.
Yes, and you should — at a different time of day, so you are not diluting the steroid or spreading it beyond the rash.
The steroid treated the inflammation, not the cause. Expected in eczema and psoriasis, and why maintenance and steady moisturizing matter.
Yes. It was developed for once-daily use and the trials were done that way. Twice a day adds side effect risk without benefit.
A short sting on broken skin is common and settles. Burning that builds over days, or a worsening rash, can mean infection or a reaction to the base.
No. It works on a different switch inside the skin cell, the aryl hydrocarbon receptor. That is why there is no time limit and no skin thinning.
Yes — approved for the face and skin folds, one of its main advantages over a steroid.
Most likely folliculitis — small red bumps around hair follicles where you applied it. The most common side effect in the trials, at roughly one in five people, usually mild, and most carried on.
Give it twelve weeks. Some change usually shows by four.
That is a normal way to use it. In the long-term study, many who cleared completely stayed clear for months, then restarted when plaques returned.
Yes, it is also approved for atopic dermatitis, in adults and in children from age two.